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ABSTRACT 
Objective: Non-compliance with heart failure medication is related to the highest mortality, morbidity, and health-care costs. The objective of this 
study was to evaluate medication compliance with patients with congestive heart failure.  
Methods: Inpatients of the cardiac care unit and medical ward of Republican Hospital, German Hospital, Revolutionary Hospital, and Chinese–
Yemeni Friendship Hospital were recruited for this study. The study was conducted on patients that were diagnosed as having congestive heart 
failure and were receiving treatment. Questionnaires were distributed and personal interviews to evaluate the patients’ compliance was conducted 
to determine the reasons for their non-compliance in taking drugs. 
Results: Of 86 patients, 44% (n = 38) reported compliance and 56% (n = 48) reported non-compliance. The distribution of the patients in terms of 
sex was as follows: among men, 41% (n = 24) were compliant and 59% (n = 35) were non-compliant; among women, 52% (n = 14) were compliant 
and 48% (n = 13) were non-compliant. In addition, smoking status was too significantly linked with non-compliance (P = 0.001). Furthermore, the 
status of chewing of khat tree leaves was also significantly associated with non-compliance (P = 0.007). 
Conclusion: This study indicates that the reasons for non-compliance with medications among patients can be attributed to lack of education, 
chewing of khat tree leaves, lack of health insurance, and cigarette smoking. Therefore, healthcare professionals should create strategies to address 
these reasons in order to increase medication compliance with patients in heart failure. 
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Heart failure (HF) is a clinical syndrome observed by breathing 
trouble, ankle enlargement, and weakness that can be accompanied 
by elevated jugular venous pressure, pulmonary crackles, and 
peripheral edema [1]. 
More than 5.7 million general public in the United States and at least 
23 million persons worldwide live with HF, which is related to 
considerable illness, death, and healthcare costs [2]. 
By 2030, the prevalence of HF in the United States is estimated to 
rise by 46% to about 8.5 million persons [3]. Numerous countries in 
the Middle East have experiential rises in the prevalence of the risk 
factors of the increase in HF [4]. Permitting to the HF guidelines on 
the European Society of Cardiology and the American Heart 
Association/American College of Cardiology, multiple medications 
(e. g., angiotensin-converting enzyme inhibitors [ACEIs], diuretics, 
beta-blockers, spironolactone, digoxin) are useful for patients with 
HF and should, therefore, was prescribed. Non-pharmacological 
routine changes, such as fluid and sodium restriction, regular 
weighing, movement adjustment, vaccination against influenza, stop 
smoking, and limiting alcohol intake, have been recommended. 
Compliance has long been documented as a significant matter in 
health care [5]. A significant first step to successful medication 
compliance is defining the factors that influence compliance. 
Accordingly, the aims at this study were to evaluate the medication 
compliance with patients with congestive heart failure. 
MATERIALS AND METHODS 
A prospective observational study with the purposive random 
sample was conducted at the cardiac inpatient department of four 
government hospitals Revolutionary Hospital, German Hospital, 
Republican Hospital, and Chinese–Yemeni Friendship Hospital in 
Sana’a, Yemen. Patients were registered prospectively for a period of 
5 mo (from March 2016 to July 2016). A validated standard 
questionnaire assessing medication adherence was used to survey 
the patients, after its translation to the Arabic language. A total of 86 
patients with congestive heart failure (CHF) underwent personal 
interviews, and related data were collected after a medical chart 
review. The diagnosis of HF was documented based on patient 
history, physical investigation, and echocardiography. The patients 
were aged>20 y, were confirmed to have a diagnosis of HF, and were 
receiving HF medications. Appropriate ethical approval was 
obtained from the involved hospitals. The data collection form was 
used to assemble the patients’ associated with data (age, sex, 
education status, the status of chewing khat tree leaves, cigarette 
smoking, medical insurance status, and prescribed drugs).  
Their current medication was obtained through the questionnaire. 
This questionnaire was offered in Arabic. Data were entered and 
examined by means of Microsoft Excel 2007 for Windows. 
Continuous data were statistically examined using Student’s t-test, 
and categorical data were analyzed using the chi-square test. 
Descriptive analysis was used to summarize the data. The level of 
significance was assigned to P<0.05. 
RESULTS 
A total of 86 patients were recorded in the present study. 69% (n = 
59) of the subjects were men, and 31% (n = 27) were women. The 
mean patient age was 56.9 (±16) years.  
The patients’ demographic characteristics are presented in table 1. 
In this study, 53(n = 46) patients were non-educated and 47% (n = 
40) were educated. In addition, 45% (n = 39) patients were non-
smokers and 55% (n = 47) patients were smokers. On the other 
hand, 44% (n = 38) patients did not chew khat tree leaves and 56% 
(n = 48) patients were chewers of khat tree leaves. Among the 
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patients, 83% (n = 71) did not have medical insurance and 17% (n = 
15) had medical insurance. The results of this study showed that the 
patients’ age had an influence on their compliance behavior 
(P<0.0001), as shown in table 2. 
In the present study, educational status was significantly linked 
with non-compliance. In group 1, the percentage of non-educated 
patients was 33% (n = 15) and the percentage of educated patients 
was 57% (n = 23). On the other hand, in group 2, the percentage of 
non-educated patients was 67% (n = 31) and the percentage of 
educated patients was 43% (n = 17). In addition, smokers were 
more than non-smokers likely to belong to the compliance group, 
consequently, smoking status was too significantly linked with 
non-compliance (P = 0.001). Furthermore, the status of chewing of 
khat tree leaves was also significantly associated with non-
compliance (P = 0.007) (table 3).  
In group 1, there were 61% (n = 23) patients that did not chew khat 
tree leaves and 31% (n = 15) patients who did chew khat tree leaves. 
In comparison, in group 2, 39% (n = 15) patients did not chew khat 
tree leaves and 69% (n = 33) patients did chew khat tree leaves (P = 
0.007). Moreover, health insurance status was also significantly 
associated with non-compliance (P = 0.002).  
In group 1, 37% (n = 26) patients had no medical insurance and 
80% (n = 12) patients were medically insured. In comparison, in 
group 2, 63% (n = 45) patients had no medical insurance and 20% 
(n = 3) patients were medically insured. 
According to the results of the present study (table 4), diuretics 
were the most prescribed medications (about 89.3% of all 
prescribed medications), followed by angiotensin-converting 
enzyme inhibitors (ACEIs), digoxin, aspirin, anticoagulants, 
nitrates, beta-blockers, and calcium channel blockers (CCBs) 
(76.5%, 63.5%, 61.6%, 57%, 30.3%, 28%, and 21%, respectively). 
On the other hand, angiotensin receptor blockers (ARBs) had a 
prescribed rate of about 13%, whereas anti-arrhythmic drugs 
were rarely prescribed (9.3%). 
In general, using the Morisky Medication Adherence Scale [6] and 
the questionnaires used during the personal interviews for the 
patients in this study, it was determined that the percentage of 
patients with medication compliance was 44% (n = 38) and that of 
non-compliant patients was 56% (n = 48) (table 5).  
The distribution of drug class according to compliance status is 
presented in fig. 1. It was found that patients had the highest 
percentages of compliance with diuretics, ACEIs, nitrates, ARBs, 
beta-blockers, and anti-arrhythmic drugs (92%, 82%, 37%, 15.8%, 
32%, and 13%, respectively). On the other hand, it was shown that 
patients had the highest rates of non-compliance to digoxin (69%), 
anticoagulants (67%), CCBs (23%), and aspirin (63%). 
 
Table 1: The demographic forms of the patients in the existing study 
Characteristic Frequency (%) 
Age, mean (±SD), 56.9±16 y 
Sex Men 59 69 
Women 27 31 
Education status Educated 40 47 
 Non-educated 46 53 
Smoking status Smoker 47 55 
 Non-smoker 39 45 
Chewing of khat tree leaves Chewer 48 56 
 Non-chewer 38 44 
Health insurance status With insurance 15 17 
 Without insurance 71 83 
SD: Standard deviation; CHF: Congestive heart failure 
 
Table 2: Distribution and influence of age among study groups 
Age* n Minimum Maximum Mean SD P-value 
Non-compliance group 48 20.00 90.00 58.8 14.9 0.0001 
Compliance group 38 20.00 85.00 54.5 16.8 
P<0.05 was considered statistically significant. SD: Standard deviation. 
 
Table 3: Compliance rate among patient groups according to study variables 
Study variable Compliance group 1 Non-compliance group 2 P-value* 
Freq % Freq % 
Sex Men 24 41 35 59 0.333 
Women 14 52 13 48 
 
Education status 
Non-educated 15 33 31 67  
0.011 Educated 23 57 17 43 
 
Smoking status 
Non-smoker 25 64 14 36  
0.001 Smoker 13 28 34 72 
 
Chewing of khat tree leaves 
Non-chewer 23 61 15 39  
0.007 Chewer 15 31 33 69 
 
Health insurance status 
Without insurance 26 37 45 63  
0.002 With insurance 12 80 3 20 
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Table 4: Distribution of medication classes in the middle of patients 
Drug class Frequency of prescribed class (%) 
Diuretics 77 89.3 
ACEIs 66 76.5 
Nitrates 26 30.3 
ARBs 12 13 
Digoxin 55 63.5 
B-blockers 24 28 
Anticoagulants 49 57 
Antiarrhythmic drugs 8 9.3 
CCBs 18 21 
Aspirin 53 61.6 
ACEIs: Angiotensin-converting enzyme inhibitors; ARBs: Angiotensin receptor blockers; CCBs: Calcium channel blockers. 
 
Table 5: Morisky scale 
Factor loadings of the four-item medication adherence scale Yes (n) No (n) 
Are you uncaring at times with taking medication? 48 38 
Do you from time to time forget to take your medications? 48 38 
When you transportable or leave home, do you on occasion forget to take along your medications? 44 42 
When you feel similar your symptoms are under control, do you sometimes discontinue taking your drug? 36 50 
 
 
Fig.1: Distribution of medication classes according to compliance status. CCBs: Calcium channel blockers; ARBs: Angiotensin receptor 
blockers; ACEIs: Angiotensin-converting enzyme inhibitors 
 
DISCUSSION 
In patients with HF, medication non-compliance adversely affects 
their qualities of life, increases mortality and morbidity, which is one 
of the major causes of recurrent hospitalizations [7]. Some studies 
indicated that up to 60% of all medications prescribed were taken 
incorrectly, or not at all [8,9]. The present study showed that the 
non-compliance rates were 56%. The study by Ni et al. found a non-
compliance rate of 23% [10]. On the other hand, Evangelista et al. 
reported a non-compliance rate of only 4% [11]. In contrast, data on 
the Asian population reported by Sayed et al.[12] showed a non-
compliance rate of 72.7%, which is high when compared with that 
was found in our study. There are different methods of assessing 
compliance with medications, and various studies have used 
different compliance assessment methods that involve different 
procedures in different patient populations, which make 
comparisons between them inaccurate. This could be a partial 
reason for the variation in compliance rates. In this study, education 
status was significantly linked with non-compliance. In group 1 in 
this study, the percentage of non-educated patients was 33% (n = 
15) and the percentage of educated patients was 57% (n = 23). On 
the other hand, in group 2, the percentage of non-educated patients 
was 67% (n = 31) and the percentage of educated patients was 43% 
(n = 17). The study by Chui et al. showed a highly significant 
association with education status with non-compliance[13].Another 
study by Berkman et al. reported that to non-educated patients, only 
43 (23.5%) werecompliant and 140 (76.5%) were non-compliant, 
whereas among educated patients, 30 (35.7%) were compliant and 
54(64.3%) were non-compliant[14]. Our results confirmed those of 
the above-mentioned studies, showing that lack of education was 
the main reason for non-compliance. Additionally, the present study 
showed a strong significant relationship to cigarette smoking with 
non-compliance. The results confirm the findings of two previous 
studies suggesting that current smokers were more likely to be non-
compliant than current non-smokers [15, 16]. Several studies have 
reported that increases to HF rate and blood pressure were 
associated with chewing of khat tree leaves [17,18]. This study 
showed that 56% (n = 48) patients were chewers of khat tree leaves, 
and most of them were non-compliant in taking medications. The 
present study found that patients that did not have health insurance 
comprise 83% of the total population, indicating that most of the 
population did not have health insurance coverage. Furthermore, 
this study showed that the compliance rates were higher in patients 
with health insurance coverage than in those without. This indicated 
that a health insurance scheme can improve medication compliance 
with patients. The study by Chi-Kwon et al. showed that patients 
who had no insurance coverage or who had a low salary were more 
likely to be non-compliant with medication [19]. The results of the 
present study confirmed the findings of Chi-Kwon et al. However, it 
is difficult to compare various studies because of differences in the 
study population, measurement instruments, and in interventions 
that were used to improve compliance. Evaluating these differences 
might explain the different outcomes. In this study, diuretics were 
the most prescribed medication (about 89.3%), followed by ACEIs, 
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digoxin, aspirin, anticoagulants, nitrates, and beta-blockers(76.5%, 
63.5%, 61.6%, 57%, 30.3%, and 28%, respectively).  
A similar study by Sayed et al. showed treatment rates of 60.2% for 
diuretics, 56.1% for ACEIs, and 38.2% for digoxin, which were lower 
than the ratios reported in this study [20]; however, their rates for 
beta-blockers (45.3%) and aspirin (78.6%) were higher than those 
of our study. According to European, American, and Canadian 
studies, 28–75% of patients with HF are prescribed with ACEIs and 
only 11.8–41% are prescribed with beta-blockers [21,22]. These 
were confirmed in our study, in which the prescription rate of beta-
blockers was 28% and that for ACEIs was 76.5%. Current guidelines 
recommend the routine use of ACEIs or ARBs, and beta-blockers in 
patients with HF, owing to their proven effectiveness in improving 
morbidity, mortality, and hospitalization rates [23]. In the present 
study, the compliance rate of ACEIs was 82%, which is low when 
compared to another study that showed a compliance rate of 92.9% 
to ACEIs[24]. Another study by Parameswaran et al. reveals that the 
rates of continued therapy with beta-blockers at 6, 12, and 24 mo 
were 69%, 70%, and 74%, respectively [25]. The outcomes of the 
present study found a compliance rate of 32% for beta-blockers, 
which is low compared to that in the previous study. The present 
study showed that the compliance rates for digoxin among patients 
with HF were 58%, which is higher than the 10% rate reported by 
Monaneet al.[26]. 
CONCLUSION 
This study indicates that the reasons for non-compliance with 
medications among patients can be attributed to lack of education, 
chewing of khat tree leaves, lack of health insurance, and cigarette 
smoking. Therefore, healthcare professionals should create 
strategies to address these reasons, and learn to recognize the risk 
and of lack of education, cigarette smoking, and chewing of khat 
leaves to increase medication compliance with patients in CHF. 
Increasing the patients’ knowledge about their disease is extremely 
useful and advisable, and might ultimately lead to a reduction in the 
incidence and prevalence of HF, which, in turn, would contribute to 
the overall improvement in the population’s health status. 
RECOMMENDATIONS 
Following is a list of recommendations specified to a medical doctor 
in a work to improve compliance: Create it clear to patients that they 
themselves take in the drug as being significant. Make available clear 
guidelines. Style the medication programs to the patient's individual 
timetable. Review the significance of compliance with patients. Give 
a basic knowledge to patients in self-monitor. Begin regular 
communication with patients. Provide cognitive to assist in the 
patients. recommend patients to stop chewing khat tree leaves. 
Approving to the heart failure (HF) guidelines on the European 
Society of Cardiology (ESC) and the American Heart 
Association/American College of Cardiology (AHA/ACC) multiple 
drugs (ACE-inhibitors, diuretics, beta-blockers, spironolactone, 
digoxin) are advantageous to heart failure (HF) patients and should, 
therefore, be prescribed (Martjeet al., 2005)[27]. The Governmental 
and Private Hospitals in Yemen required clinical pharmacist for the 
reason that the clinical pharmacist can donate to confident result by 
teaching and recommend patients to prepare and encourage them to 
monitor their beneficial course of therapy and specialist care plans. 
The clinical pharmacist can make available best medication therapy 
to increase a patient’s quality of natural life by treatment of disease. 
The community-founded pharmacist is one that has a direct 
contribution to a patient’s treatment strategy, has direct and 
repeated communication with the medical doctor. The community-
founded pharmacist can develop compliance and shares this 
evidence of the medical doctor to develop patient’s carefulness and 
medication compliance (Dunbar-Jacobet al., 2001)[28]. 
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